Patent Assignment
Reel/Frame 065672/0674
Assignment of Assignor's Interest
Recorded: 2023-11-27
Pages: 12
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Novel Lipids and Compositions for the Delivery of Therapeutics
Application:
18/110,791 →
Publication:
US 2023/0381319
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 18, 2023
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; JAYARAMAN, MUTHUSAMY; BUTLER, DAVID
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 065611/0669 →
Change of Name
Dec 7, 2023
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 065802/0675 →
Merger
Jan 20, 2024
From: PROTIVA BIOTHERAPEUTICS, INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 066357/0259 →